As of 2025-05-29, the Net Margin of Vaxcell Bio Therapeutics (323990.KQ) is -559.4%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
Date | Value |
---|---|
2024-12-31 | -559.4% |
2023-12-31 | -74867.6% |
2022-12-31 | - |
2021-12-31 | - |
2020-12-31 | - |
2019-12-31 | - |
2018-12-31 | - |
- | |
- | |
- |